Home › Graft-Versus-Host Disease › Ohio › Cleveland
Graft-Versus-Host Disease clinical trials in Cleveland, OH
3 studies for Graft-Versus-Host Disease are looking for participants at sites in and around Cleveland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation
RecruitingObservational study
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
RecruitingPhase 3
- Cleveland Clinic, Cleveland
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
RecruitingPhase 2
- Cleveland Clinic, Cleveland
Graft-Versus-Host Disease trials in other cities
- Boston, MA10 studies
- New York City, NY7 studies
- Columbus, OH6 studies
- Atlanta, GA5 studies
- Washington, DC5 studies
- St. Louis, MO4 studies
- Portland, OR4 studies
- Baldwin Park, CA4 studies
- Tampa, FL4 studies
- Detroit, MI4 studies
- Pittsburgh, PA4 studies
- Miami, FL4 studies
Other studies in Cleveland
- Non-Small Cell Lung Cancer43 studies
- Cancer (all types)36 studies
- Breast Cancer35 studies
- Prostate Cancer34 studies
- Heart Failure33 studies
- Metastatic Cancer30 studies
- Ovarian Cancer30 studies
- Lung Cancer26 studies
- Colorectal Cancer24 studies
- Cardiovascular Disease22 studies
- Endometrial Cancer20 studies
- Acute Myeloid Leukemia20 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.